Skip to main page content

Thuy Doan MD, PhD

Participates in 8 items

Dr. Thuy Doan obtained her MD at Stanford University and her PhD in Neurobiology & Behavior at the University of Washington, Seattle. She completed her ophthalmology residency and uveitis fellowship at the University of Washington. She is currently an Associate Professor at the University of California, San Francisco (UCSF), where she takes care of patients with ocular surface and intraocular inflammatory diseases. Dr. Doan also runs a metagenomic epidemiology laboratory that utilizes innovative technical approaches and randomized controlled trials to understand how human microbiomes (ocular, gut, and upper respiratory tract) respond to clinically relevant perturbations. In addition, her group uses genomic methods to efficiently identify infectious agents and biomarkers for ocular inflammatory diseases. The team is highly collaborative and works extensively with international partners and investigators. Her research is funded by the National Institutes of Health (NIH-NEI), the Bill and Melinda Gates Foundation, the Research to Prevent Blindness, the Huang Foundation, and All May See.

Financial disclosure: Dr. Doan has/had an affiliation (financial or otherwise) with a commercial organization.

  1. Bill & Melinda Gates Foundation
  2. National Institute of Health
  3. Huang Foundation
  4. Research to Prevent Blindness (RPB)
  5. All May See

Sessions in which Thuy Doan MD, PhD participates

viernes 10 junio, 2022

Zona horaria: (GMT-05:00) Eastern Time (US & Canada)
7:00
7:00 - 9:00 | 2 hours
Current Concepts

Learning ObjectivesAt the end of this session, participants will be able to:Determine the ocular conditions associated with obstructive sleep apneaDescribe how racism operates within health care in parallel ways to how racism operates in other settingsProvide a framework for how we can move from supportive statements to anti-racist actionCanMEDS Roles: Medical Expert, Scholar

8:15
8:15 - 8:25 | 10 minutos
Current ConceptsUveitis
12:30
12:30 - 14:00 | 1 hour 30 minutos
Uveitis

At the end of this session participants will be able to:• Demonstrate increased knowledge on the use of biosimilar agents and fluid analysis in the diagnosis and management of uveitis. • Integrate pearls on the management of ocular hypertension, postoperative inflammation in uveitis. CanMEDS Roles: Medical Expert, Scholar 

12:50
12:50 - 13:00 | 10 minutos
Uveitis

jueves 11 septiembre, 2025

Zona horaria: (GMT-05:00) Eastern Time (US & Canada)